Medicare GLP-1 Coverage in 2027: Diabetes, Weight Loss and the $50 Bridge

Medicare now covers GLP-1s for diabetes and, for a limited time, for weight loss. Here's who qualifies, what each drug costs in 2027 and how to compare plans.

Does Medicare Cover GLP-1 Medications?

Yes, in two ways. Part D covers GLP-1s such as Ozempic, Mounjaro and Trulicity when they're prescribed for type 2 diabetes. That includes standalone Part D plans and Medicare Advantage plans with drug coverage.

For weight loss, the answer changed on July 1, 2026. Through the Medicare GLP-1 Bridge, eligible enrollees pay $50 a month for Wegovy (injection and tablets), Foundayo and Zepbound KwikPen. The Bridge ends Dec 31, 2027.

GLP-1 medications act like a hormone your body makes to help control blood sugar and appetite. Common ones include semaglutide (Ozempic, Rybelsus, Wegovy), liraglutide (Victoza), dulaglutide (Trulicity), tirzepatide (Mounjaro, Zepbound) and orforglipron (Foundayo, a daily pill).

Parts A and B cover hospital and medical services, not the GLP-1s you fill at a pharmacy. Each Part D plan keeps its own formulary, a list of covered drugs sorted into cost tiers, so your plan decides which GLP-1s it covers and what you pay.

The Medicare GLP-1 Bridge for Weight Loss

The Medicare GLP-1 Bridge is a temporary program for weight loss. It charges $50 a month for eligible drugs from July 1, 2026 through Dec 31, 2027. To qualify, you need:

• Medicare Part D or a Medicare Advantage plan with drug coverage

• A prescription for weight loss, used along with lifestyle changes such as diet and physical activity

• An approved prior authorization, which includes BMI criteria

The Bridge covers Wegovy (injection and tablets), Foundayo and Zepbound KwikPen only. Zepbound single-dose vials and single-dose pens are not included. If you use one of those, ask your prescriber whether the KwikPen is an option for you.

Two details matter for your budget. The $50 copay doesn't count toward the Part D out-of-pocket cap, and Extra Help (the Low-Income Subsidy) doesn't lower it. Humana runs the Bridge as the central processor for Medicare (KFF).

Your prescriber starts the process with the prior authorization form on the CMS Medicare GLP-1 Bridge page.

More on each drug: Foundayo Medicare coverage, Does Medicare cover Zepbound and Wegovy for seniors.

GLP-1 Coverage for Type 2 Diabetes Under Part D

Part D plans cover GLP-1s for type 2 diabetes, often after a first-line treatment such as metformin hasn't controlled blood sugar well enough. Your prescriber documents your treatment history to show the medication is medically necessary.

Ozempic is covered for diabetes, not weight loss. If you're looking into Ozempic online prescriptions for weight loss, Part D won't pay for that use. For weight loss, the Bridge covers Wegovy, which has the same active ingredient, semaglutide.

Some plans use step therapy, which means you try a lower-cost diabetes medication before the plan covers a GLP-1. Rules vary by plan, so check your formulary before you talk through options with your prescriber.

Asking about tirzepatide? Read Is Mounjaro covered by Medicare.

Medicare GLP-1 Formulary Options at a Glance

Here's how the main GLP-1s line up under Medicare in 2027. For diabetes drugs, your plan's formulary still sets the tier, prior authorization and step therapy rules.

What GLP-1s Cost With Medicare in 2027

Part D costs in 2027 follow three phases (PBS NewsHour):

That $2,400 cap limits what you pay for covered Part D drugs, including diabetes GLP-1s, in 2027.

Medicare's negotiated prices for Ozempic, Rybelsus and Wegovy take effect Jan 1, 2027. For Ozempic and Rybelsus, what you pay still depends on your plan's tier and which phase you're in. Wegovy for weight loss stays at $50 a month through the Bridge.

Extra Help (the Low-Income Subsidy) can lower Part D premiums, deductibles and copays if you have limited income and resources. Check your plan or Medicare for 2027 amounts.

For the full picture, read Medicare Part D in 2027.

Prior Authorization, Formularies and Appeals

Most plans require prior authorization for GLP-1s. Your prescriber sends your medical history, current medications and, for diabetes, your blood sugar records. Review times vary by plan and by whether the request is urgent, so ask your plan how long its review takes.

Formularies sort drugs into tiers, and the tier sets your copay. Brand-name GLP-1s often sit on higher tiers.

Ongoing treatment has its own rules, so check how prescription refills work on your plan. Check whether your plan requires prior authorization renewals or limits first fills.

If your plan denies coverage, you can appeal through several levels of review. Your prescriber can send more records to support the request. Your denial notice explains the steps and deadlines.

How to Compare Part D Plans for GLP-1 Coverage

1. Read your Annual Notice of Change. Your plan sends it each fall, and it lists next year's formulary and cost changes.

2. Open Medicare Plan Finder on Medicare.gov and enter your exact GLP-1 and dose.

3. Check which tier each plan puts your GLP-1 on.

4. Check whether each plan requires prior authorization or step therapy for it.

5. Compare the total yearly cost, including premium and deductible, not just the copay.

6. Make any switch during open enrollment, and confirm your GLP-1 is on the new plan's formulary first.

Medicare vs Private Insurance for GLP-1s

Private plans vary widely. Some cover GLP-1s for weight loss and some don't, and the rules can change between employers and from year to year.

Medicare now has two paths: Part D for type 2 diabetes, and the Bridge for weight loss (Wegovy, Foundayo and Zepbound KwikPen) through 2027. Medicare Advantage plans with drug coverage can use the Bridge too, though their formularies, tiers and prior authorization rules for diabetes GLP-1s differ by plan.

Employer plans may list more GLP-1 options. Medicare's rules for who qualifies are the same nationwide, but each plan still sets its own formulary and tiers.

What Happens After 2027

Coverage of weight-loss GLP-1s after Dec 31, 2027 hasn't been decided. Don't count on the $50 price past that date. Recheck your options at the next open enrollment, and read your plan's Annual Notice of Change when it arrives.

Getting a GLP-1 Prescription or Refill Through Medicare Telehealth

Medicare telehealth flexibilities run through Dec 31, 2027 (APTA, HHS). You can have a visit from home, with no geographic limits.

Is it worth a morning off and a waiting room to ask about a GLP-1 or a renewal? A renewal is a new prescription so you can keep getting refills. A licensed doctor can see you by video on Doctronic and send a prescription to your pharmacy if it's right for you. Doctronic accepts Medicare.

Frequently Asked Questions

Does Medicare cover Ozempic and Wegovy for weight loss?

Wegovy, yes, for eligible enrollees. Through the Medicare GLP-1 Bridge, Wegovy (injection and tablets) costs $50 a month for weight loss through Dec 31, 2027, with prior authorization. Ozempic is covered under Part D for type 2 diabetes, not for weight loss.

How much will I pay for GLP-1 medications with Medicare Part D?

It depends on your plan. In 2027 you pay a deductible of up to $700, then your plan's copay or coinsurance. Once you've paid $2,400 out of pocket, covered drugs cost $0. Bridge drugs cost $50 a month, outside that cap. Extra Help can lower Part D costs if you qualify, but not the Bridge copay.

Can I appeal if Medicare denies my GLP-1 prescription coverage?

Yes. Medicare gives you several levels of appeal. Follow the steps and deadlines in your denial notice, and ask your prescriber to add records that back up the request.

Do I need prior authorization for all GLP-1 medications under Medicare?

Most plans require it for diabetes GLP-1s, though some cover certain ones without it. Check your plan's formulary. The GLP-1 Bridge requires prior authorization for every enrollee.

Will switching Medicare plans affect my current GLP-1 coverage?

Yes, it can. A new Part D or Medicare Advantage plan may use a different formulary, need a new prior authorization or put your GLP-1 on a different tier. Check the new plan's formulary before you switch.

Can a GLP-1 be covered under Medicare Part B instead of Part D?

Usually not. Part B covers drugs given in a doctor's office or clinic. GLP-1s you take at home are filled at a pharmacy, so they fall under Part D or the GLP-1 Bridge.

Where do I find the Medicare GLP-1 Bridge prior authorization form?

Your prescriber gets it from the CMS Medicare GLP-1 Bridge page, fills it in and sends it for you. You don't need to file it yourself.

The Bottom Line

Medicare covers GLP-1s for type 2 diabetes under Part D. For weight loss, the GLP-1 Bridge offers Wegovy, Foundayo or Zepbound KwikPen at $50 a month from July 1, 2026 through Dec 31, 2027. Prior authorization applies to every Bridge prescription and to most diabetes prescriptions. In 2027, what you pay out of pocket for covered Part D drugs stops at $2,400, though the Bridge copay sits outside that cap. Check your plan's formulary and Annual Notice of Change, and recheck your coverage before 2028.